Detalles de la búsqueda
1.
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.
Clin Infect Dis
; 76(3): e460-e468, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580849
2.
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
J Infect Dis
; 226(5): 797-807, 2022 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385875
3.
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
J Infect Dis
; 225(10): 1694-1700, 2022 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932114
4.
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
Clin Infect Dis
; 74(9): 1515-1524, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358310
5.
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
Clin Infect Dis
; 75(Suppl 2): S159-S166, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675695
6.
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(12): 459-465, 2022 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35324878
7.
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
MMWR Morb Mortal Wkly Rep
; 71(4): 118-124, 2022 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085218
8.
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.
MMWR Morb Mortal Wkly Rep
; 70(20): 753-758, 2021 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014909
9.
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
MMWR Morb Mortal Wkly Rep
; 70(38): 1337-1343, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34555004
10.
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
MMWR Morb Mortal Wkly Rep
; 70(34): 1156-1162, 2021 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34437524
11.
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
JAMA
; 326(20): 2043-2054, 2021 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34734975
12.
Universal Masking in Health Care Settings: A Pandemic Strategy Whose Time Has Come and Gone, For Now.
Ann Intern Med
; 176(6): 859-861, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068281
13.
Characterization of Aerosols Generated During Patient Care Activities.
Clin Infect Dis
; 65(8): 1335-1341, 2017 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29017249
14.
Perceptions and behaviours of infectious diseases physicians when managing urinary tract infections due to MDR organisms.
J Antimicrob Chemother
; 70(12): 3397-400, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26349519
15.
Respiratory Protection of Health Care Personnel to Prevent Respiratory Viral Transmission.
JAMA
; 322(9): 817-819, 2019 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31479123
16.
Assessment of the characteristics of COVID-19 infection among healthcare personnel working in long-term care facilities.
Antimicrob Steward Healthc Epidemiol
; 4(1): e81, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721487
17.
Knowledge, beliefs, and practices related to coronavirus disease 2019 (COVID-19) infection and vaccination in healthcare personnel working at nonacute care facilities.
Infect Control Hosp Epidemiol
; 44(10): 1657-1662, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36987862
18.
Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020-April 2021.
Antimicrob Steward Healthc Epidemiol
; 3(1): e133, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592963
19.
Association between SARS-CoV-2 Symptoms, Ct Values, and Serological Response in Vaccinated and Unvaccinated Healthcare Personnel.
J Appl Lab Med
; 8(5): 871-886, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37478837
20.
Introduction to A Compendium of Strategies to Prevent Healthcare-Associated Infections In Acute-Care Hospitals: 2022 Updates.
Infect Control Hosp Epidemiol
; 44(10): 1533-1539, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855077